Related by context. All words. (Click for frequent words.) 72 microbleeds 70 MMSE scores 69 subcortical 68 infarcts 68 cerebral infarction 66 carotid stenosis 66 autonomic dysfunction 66 neurological abnormalities 66 hippocampal volumes 66 anterior temporal 66 cognitively normal 65 subclinical hypothyroidism 65 cortical atrophy 65 cardioembolic stroke 65 affective psychoses 65 GBA mutations 65 hippocampal volume 65 neurologic complications 65 neuroimaging studies 65 syndromal 64 amnestic MCI 64 thyrotropin levels 64 medial temporal 64 microvascular disease 64 hamartomas 64 euthymic patients 64 LV dysfunction 64 hippocampal atrophy 64 extrapyramidal symptoms 64 subclinical atherosclerosis 64 alexithymia 64 noncardiac 64 brain lesions 64 rCBF 64 nondepressed 64 ischemic lesions 64 neurocognitive deficits 63 hypoperfusion 63 infarctions 63 nonischemic 63 serum BDNF 63 proliferative diabetic retinopathy 63 atypical hyperplasia 63 asymptomatic carotid stenosis 63 coronary calcification 63 MMSE score 63 underwent coronary angiography 63 elevated homocysteine 63 parkinsonism 63 hippocampal 63 impaired cognition 63 cerebellar 63 subclinical hyperthyroidism 63 APOE e4 63 hyperintensities 63 carotid plaque 62 cerebrovascular events 62 troponin T 62 ADPKD 62 perimenopausal women 62 left ventricular diastolic 62 elevated triglyceride levels 62 neuropathological 62 affective psychosis 62 neurocognitive function 62 hyperintense lesions 62 cognitive impairment 62 nonfasting triglycerides 62 meningioma 62 androgen deficiency 62 cortical thinning 62 Subgroup analyzes 62 CHD mortality 62 cardiac dysfunction 62 intracranial atherosclerosis 62 Mild cognitive impairment 62 periventricular 62 somatic symptoms 62 prefrontal regions 62 supratentorial 62 fractional anisotropy 62 Alzheimer pathology 62 cerebral microbleeds 62 intima media thickness 62 carotid atherosclerosis 62 penetrance 62 APOE e4 gene 62 primary aldosteronism 62 comorbid disorders 62 systolic dysfunction 62 POAG 62 neurosensory 62 microvascular complications 61 telomere lengths 61 neurologic symptoms 61 OSAHS 61 poorer prognosis 61 NP CRNs 61 TEAEs 61 T2 lesions 61 ependymomas 61 lesional 61 untreated OSA 61 myocardial infarction MI 61 colorectal neoplasia 61 CP CPPS 61 APOE ε4 61 diabetes mellitus DM 61 myocardial infarctions 61 periprocedural MI 61 nonfatal MI 61 MetS 61 Genetic variants 61 ejection fractions 61 lacunar 61 prolonged QT interval 61 postoperative delirium 61 advanced adenoma 61 intact parathyroid hormone 61 arterial thickening 61 familial clustering 61 neurodevelopmental impairment 61 macrovascular disease 61 MGUS 61 undergoing CABG 61 adenoma 61 vascular dementia 61 nondiabetic patients 61 neurocognitive impairment 61 Cognitive impairment 61 coronary artery calcium 61 isolated systolic hypertension 61 intracerebral haemorrhage 61 fasting insulin 61 poststroke 61 asymptomatic PAD 61 vascular cognitive impairment 61 hypometabolism 61 osteosarcomas 61 proliferative retinopathy 61 cerebral infarcts 61 seminomas 61 gyri 61 atherothrombotic disease 61 meningiomas 61 TT genotype 61 non affective psychosis 60 anticholinergic drugs 60 cystatin C 60 interindividual variability 60 cTnT 60 echocardiographic parameters 60 coronary blockages 60 sporadic ALS 60 chronicity 60 elevated CRP 60 cognitive domains 60 prefrontal cortical 60 hippocampal function 60 gene APOE 60 carotid IMT 60 clinically insignificant 60 perfusion defects 60 intracranial stenosis 60 aortic stiffness 60 allodynia 60 arterial thromboembolic events 60 hyperacute 60 depressive symptomatology 60 stress cardiomyopathy 60 biochemical recurrence 60 cingulate gyrus 60 coronary calcium 60 T2DM 60 cortical regions 60 Ischemic strokes 60 clinicopathologic 60 overt hypothyroidism 60 psychosocial functioning 60 microalbuminuria 60 Lewy bodies 60 albuminuria 60 androgen depletion 60 schwannomas 60 cardiovascular mortality 60 nonmelanoma skin cancers 60 colorectal adenoma 60 MACCE 60 plasma folate 60 psychiatric comorbidities 60 generalized seizures 60 malperfusion 60 left ventricular systolic 60 HRCT 60 cerebral infarctions 60 preoperative chemotherapy 60 cardiorespiratory fitness 60 synesthetes 60 clinicopathological 60 colorectal adenomas 60 de novo mutations 60 left ventricular dysfunction 60 gastric carcinoma 60 preserved ejection fraction 60 narcolepsy cataplexy 60 temporoparietal junction 60 hematopoietic cancers 60 parahippocampal gyrus 60 hyperplastic 60 CALHM1 60 aortic atherosclerosis 60 obstructive CAD 60 ischemic stroke 60 salivary cortisol 60 gadolinium enhanced 60 genetic polymorphisms 60 airflow obstruction 60 LV ejection fraction 60 familial pancreatic cancer 60 FXTAS 60 posterior cingulate 59 neuropsychiatric symptoms 59 subsyndromal 59 parenchymal 59 calculi 59 cortical thickness 59 Brugada syndrome 59 neuropathologic 59 CT perfusion 59 anterior cingulate 59 carotid plaques 59 2D 4D ratio 59 LVNC 59 incidentalomas 59 recurrent VTE 59 ischemic strokes 59 Hippocampal 59 nondiabetic 59 coronary artery calcification 59 premorbid 59 impaired fasting glucose 59 genetic loci 59 laterality 59 microemboli 59 ruptured aneurysms 59 metabolic abnormalities 59 CVD mortality 59 lobular breast cancer 59 FDG uptake 59 carcinomatosis 59 serum homocysteine 59 transaminase levels 59 liver metastasis 59 cryptogenic 59 artery stenosis 59 periprocedural 59 nonobstructive CAD 59 serum creatinine levels 59 heterozygotes 59 serum phosphate 59 conventional angiography 59 PSADT 59 5 HTTLPR 59 LVEF 59 rs# [002] 59 thyroid nodules 59 familial ALS 59 cortisol secretion 59 HbF 59 PsA 59 BDNF gene 59 haemorrhagic stroke 59 nasal obstruction 59 Hashimoto thyroiditis 59 Venous thromboembolism 59 hemorrhagic strokes 59 parietal cortices 59 neurocognitive functioning 59 S#A# [002] 59 abnormalities 59 subcortical structures 59 subclinical 59 neurofibromas 59 postoperative complication 59 symptomatic VTE 59 neuropsychological impairments 59 fasting glucose levels 59 Wernicke encephalopathy 59 KCNH2 59 atherosclerotic lesion 59 left ventricular hypertrophy 59 lymph node involvement 59 vmPFC 59 comorbid depression 59 HIV HCV coinfected 59 multivariable adjusted 59 nondemented 59 oxygen desaturation 59 thalamic 59 voxel 59 affective disorders 59 brain infarcts 59 CSF biomarkers 59 carotid artery thickness 59 generalized epilepsy 59 Coronary artery calcium 59 advanced adenomas 59 macroalbuminuria 59 APOE genotype 59 left ventricular LV 59 aortic regurgitation 59 malignant neoplasm 59 nodal metastases 59 abnormal lipid 59 allele frequencies 59 Chronic insomnia 59 silent ischemia 59 myocardial ischemia 59 Mild Cognitive Impairment 59 Obstructive sleep apnea 59 subarachnoid hemorrhages 59 diastolic function 59 oncologic outcomes 59 genetic variants associated 59 activated microglia 59 revascularization procedures 59 Sjögren syndrome 59 coronary stenosis 59 BRCA1 mutations 59 amyloid deposits 59 morphologic 59 arterial stiffening 59 QT intervals 59 HbA 1c 59 APOE4 59 postoperative AF 59 inherited mutations 59 pathophysiologic 59 ABCB1 58 depressive symptom 58 cognitive dysfunction 58 pulmonary nodules 58 familial aggregation 58 diffusion tensor 58 histologically 58 atherosclerotic lesions 58 Brodmann Area 58 PNES 58 CIN3 58 nonvertebral fracture 58 typical antipsychotics 58 medial frontal cortex 58 mammillary bodies 58 aneurysmal subarachnoid hemorrhage 58 carcinoids 58 VaD 58 synaptic function 58 untreated celiac disease 58 T1DM 58 hepatic lesions 58 spirometric 58 ischemic cardiomyopathy 58 polypoid lesions 58 deCODE BreastCancer TM 58 intracranial hemorrhage ICH 58 endometrial carcinoma 58 advanced neoplasia 58 subtrochanteric 58 β blockers 58 postoperative mortality 58 prostate cancer CaP 58 circulating EPCs 58 angiotensin receptor blockers ARBs 58 postintervention 58 diastolic dysfunction 58 nonalcoholic steatohepatitis NASH 58 hypercoagulable 58 poor metabolizers 58 somatoform disorders 58 CHD CVD 58 perioperative mortality 58 pCR 58 episodic migraine 58 prostate carcinogenesis 58 Multivariate analyzes 58 sCJD 58 malignant lesions 58 cortices 58 precuneus 58 symptomatic intracranial 58 plasma homocysteine 58 carotid artery blockage 58 abdominal adiposity 58 elevated cortisol 58 Subgroup analysis 58 orbitofrontal 58 albumin excretion 58 hepatocellular carcinomas 58 affective disorder 58 elevated LDH 58 angiographically 58 subcortical regions 58 oculomotor 58 carcinoid 58 thyrotropin 58 stratifying patients 58 underlying pathophysiology 58 caudate 58 amnestic mild cognitive impairment 58 electrophysiologic 58 ventricular enlargement 58 gallstone disease 58 lymph node metastases 58 hippocampi 58 elevated IOP 58 prospective longitudinal 58 autosomal dominant inheritance 58 hyperglycaemia 58 thromboembolic 58 elevated serum creatinine 58 vasogenic edema 58 autistic traits 58 synaesthetes 58 cognitively intact 58 FDG PET scans 58 cognitive affective 58 tau protein tangles 58 fMRI scans 58 Vascular dementia 58 ataxias 58 BMPR2 58 migraineurs 58 CTEPH 58 aminotransferases 58 calcified plaque 58 temporoparietal 58 Longitudinal studies 58 hsCRP 58 leukocytosis 58 diastolic hypertension 58 glioma tumors 58 preoperative PSA 58 estrogen receptor negative 58 postoperative atrial fibrillation 58 Takotsubo cardiomyopathy 58 serous ovarian cancer 58 SUVmax 58 colorectal neoplasms 58 hormone receptor negative 58 LQTS 58 calcified plaques 58 radical nephrectomy 58 homozygotes 58 monoclonal gammopathy 58 cardiac troponin 58 amyloid deposition 58 arterial calcification 58 hip BMD 58 metastatic lesions 58 venous thrombosis 58 elevated triglycerides 58 elevated uric acid 58 Orthostatic hypotension 58 echogenicity 58 euthymic 58 cardiac autonomic 58 PCNSL 58 postoperative morbidity 58 inflammatory biomarkers 58 postoperative complications 58 astrocytomas 58 ecchymosis 58 fusiform gyrus 58 Hachinski 58 severe periodontitis 58 haemorrhagic strokes 58 definite stent thrombosis 58 soluble CD# ligand 58 Prehypertension 58 gamma oscillations 58 amygdalae 58 paroxysmal AF 58 carotid artery narrowing 58 multivessel disease 58 vasovagal syncope 58 cerebral oxygenation 57 thunderclap headache 57 extracolonic findings 57 microangiopathy 57 neovascular glaucoma 57 Mitral regurgitation 57 subgenual cingulate 57 tic severity 57 nonfasting triglyceride levels 57 N acetylaspartate 57 acute myocardial infarctions 57 prodromal symptoms 57 hemorrhagic complications 57 colorectal polyp 57 esophageal squamous cell carcinoma 57 unprovoked seizures 57 silent myocardial ischemia 57 sub syndromal 57 intracerebral hemorrhages 57 ximelagatran 57 brain shrinkage 57 pressor response 57 preserved systolic 57 sensorineural hearing loss 57 nondiabetics 57 glaucomatous 57 angular gyrus 57 serum estradiol 57 SCr 57 perfusion abnormalities 57 lymphocytosis 57 Erythropoietic therapies may 57 FTLD 57 renal artery stenosis 57 CC genotype 57 stenoses 57 embolic stroke 57 lactate dehydrogenase LDH 57 Stent thrombosis 57 elevated creatinine 57 hyperprolactinemia 57 sonographically 57 neuronal plasticity 57 relapsing remitting 57 juvenile idiopathic arthritis 57 comorbidity 57 frontotemporal dementia 57 systolic hypertension 57 Histologic 57 HER2 expression 57 serum uric acid 57 perioperative complications 57 prodrome 57 PNH patients 57 mild cognitive impairment 57 infarct size 57 neurologic impairment 57 colorectal liver metastases 57 ventricular tachyarrhythmia 57 lateral orbitofrontal cortex 57 da mage 57 ventricular mass 57 apnea hypopnea index 57 myopia nearsightedness 57 leiomyomas 57 highest tertile 57 atypia 57 vestibular schwannomas 57 autoregulation 57 gadolinium enhancing lesions 57 Leydig cell 57 hemiparesis 57 benign breast 57 comorbid conditions 57 APOE gene 57 intracranial hypertension 57 etiologic 57 frontotemporal 57 infarct 57 lipid lowering medications 57 cerebral vasospasm 57 Depressive symptoms 57 somatic mutations 57 PTPN# 57 serum PTH 57 insulin resistance syndrome 57 pleural effusions 57 cardiomyopathies 57 comorbid anxiety 57 thyroid carcinoma 57 SLNB 57 hyperintensity 57 postmenopausal hormones 57 Hurthle cell 57 depressive symptoms 57 artery blockages 57 silent brain infarcts 57 NAFLD 57 transient ischemic attacks 57 extracranial 57 monogenic 57 inflammatory markers 57 vascular dysfunction 57 middle frontal gyrus 57 thrombotic events 57 renal tumors 57 predisposing factor 57 atherothrombotic 57 GH deficiency 57 physiological arousal 57 NSTEMI 57 #.#ng/ml 57 gastric cardia 57 spontaneous regression 57 onset atrial fibrillation 57 chronic periodontitis 57 mucinous 57 cortical 57 IPAH 57 troponins 57 cardioembolic 57 Lp PLA2 57 carcinoid tumor 57 neuropsychological deficits 57 SRBD 57 platelet reactivity 57 myocardial ischaemia 57 hyperalgesia 57 Prostatitis 57 hematuria 57 exotropia 57 syncopal 57 subconjunctival hemorrhage 57 beta blocker therapy 57 ACh 57 cerebral atrophy 57 neovascular AMD 57 ipsilateral stroke 57 dysbindin 57 recurrent ischemic stroke 57 cerebral angiography 57 amygdala reactivity 57 Genetic predisposition 57 idiopathic Parkinson disease 57 LUTS 57 MTHFD1L gene 57 adrenal function 57 timepoints 57 postinjury 57 neovascular 57 lymphopenia 57 neurocognitive 57 chest radiography 57 antihypertensive therapy 57 endophenotypes 57 fragility fractures 57 HNSCC 57 Atypical antipsychotics 57 Colon polyps 57 PRADAXA #mg 57 electroencephalographic 57 allostatic load 57 superior temporal gyrus 57 posterior fossa 57 colonic polyps 57 sulcal 57 rebleeding 57 tumor histology 57 brain parenchyma 57 #q#.# deletion syndrome 57 distal colon cancer 57 mild cognitive 57 untreated sleep apnea 57 rs# [004] 57 Wernicke Korsakoff syndrome 57 Sleep disordered breathing 57 orbital frontal cortex 57 neuropathies 57 #q#.# [002] 57 diastolic pressures 57 cortical activation 57 carotid intima media 57 Parkinsonian Syndromes 57 glomerular filtration 57 dissociative disorders 57 metabolic parameters 57 mIU L 57 Baseline characteristics 57 persistent pulmonary hypertension 57 urate levels 57 parietal 57 artery calcification 57 acetabular dysplasia 57 elevated ALT 57 thrombocytopenic 57 microsatellite instability 57 coronary stenoses 57 chromosomal rearrangement 57 uveal melanoma 57 amyloid pathology 57 5 HTT gene 57 mmHg diastolic 56 PCa 56 neuronal dysfunction 56 corticobasal degeneration 56 heterotaxy 56 nonischemic cardiomyopathy 56 apolipoprotein E APOE 56 cerebrovascular accidents 56 temporal cortex 56 noncarriers 56 VADT 56 LV hypertrophy 56 Rectal cancer 56 Ischemic stroke 56 mammographic density 56 neutrophil counts 56 SLC#A# [002] 56 noncardiovascular mortality 56 treatment emergent AEs 56 hypertensives 56 neurologic abnormalities 56 rs# [001] 56 adnexal mass 56 situs inversus 56 Heritability 56 thyroid dysfunction 56 nonhereditary 56 renal dysfunction 56 multivariate adjustment 56 non aspirin NSAIDs 56 baseline HbA1c 56 neurodevelopmental outcomes 56 intensive statin therapy 56 unipolar depression 56 tertiles 56 adenomatous 56 amnestic 56 anemia hemoglobin 56 perirhinal cortex 56 metabolic acidosis 56 amisulpride 56 PASI scores 56 SGPT 56 parietal regions 56 parkinsonian 56 cytogenetic abnormalities 56 rACC 56 serum folate concentrations 56 jugular venous 56 renal cell carcinomas 56 psychiatric morbidity 56 hypersomnia 56 fronto temporal dementia 56 hormone therapy estrogen 56 colorectal polyps 56 Cluster headaches 56 gene polymorphisms 56 recurrent venous thromboembolism 56 DNA methylation patterns 56 hypopituitarism 56 ε4 56 nonobese 56 Relapsing remitting MS 56 preintervention 56 neurologic outcomes 56 lung resections 56 Kaplan Meier curve 56 EBV infection 56 schizotypal traits 56 glycated hemoglobin levels 56 benign thyroid nodules 56 transient ischemic attack 56 hepatectomy 56 p tau 56 type2 diabetes 56 plasma creatinine 56 vestibular dysfunction 56 androgen deprivation 56 cholinergic tone 56 anatomical abnormalities 56 obstructive coronary 56 PLX STROKE targeting 56 ARVD 56 metabolic syndrome MetS 56 anterior uveitis 56 RLS sufferers 56 axillary lymph nodes 56 facial wrinkling 56 metabolically healthy 56 parietal lobes 56 aspartate aminotransferase AST 56 PSA kinetics 56 univariate analyzes 56 clinically detectable 56 medial temporal lobe 56 dopaminergic therapy 56 alanine aminotransferase ALT 56 scintigraphic 56 Excessive daytime sleepiness 56 hypoxemia 56 Diabetic neuropathy 56 coronary revascularization 56 cerebral glucose metabolism 56 SNHL 56 gliosis 56 ictal 56 myocardial fibrosis 56 Suicidal ideation 56 brain atrophy 56 decompensated heart failure 56 micrometastases 56 TP# mutations 56 atherosclerotic disease 56 renal cysts 56 circadian genes 56 serum PSA 56 microscopic colitis 56 atherogenic dyslipidemia 56 T2 weighted images 56 reinfarction 56 atherosclerotic cardiovascular disease 56 polycystic ovary syndrome PCOS 56 neuritic 56 geographic atrophy 56 Complication rates 56 serum urate levels 56 serum vitamin D 56 malignant nodules 56 daytime sleepiness 56 progressive neurodegenerative disorder 56 paraganglioma 56 ICDs implanted 56 bulimia nervosa 56 varicocele 56 cryptogenic stroke 56 myocyte 56 medial prefrontal 56 #q# deletion 56 dyssynchrony 56 atrophic gastritis 56 ovarian hormones 56 ECG abnormalities 56 Endothelial dysfunction 56 B7 H3 56 coronary revascularization procedures 56 chest radiographs 56 inferior frontal 56 abnormal glucose tolerance 56 psychiatric comorbidity 56 creatine kinase MB 56 NIHSS 56 noncalcified 56 histopathologic 56 neurocognitive impairments 56 FASPS 56 thyroglobulin 56 entorhinal cortex 56 pathophysiologic mechanism 56 probands 56 underwent resection 56 hydroxyvitamin D concentrations 56 coronary revascularizations 56 bivariate analyzes 56 mesotheliomas 56 neurological disorder affecting 56 ductal breast cancer 56 serum calcium 56 APOE e4 allele 56 bullous pemphigoid 56 monozygotic twins 56 variant angina 56 mm Hg diastolic 56 carotid artery stenosis 56 atypical ductal hyperplasia 56 Pancreatic neuroendocrine tumors 56 androgen excess 56 differentiated thyroid 56 chromosome #q# [001] 56 EoE 56 VT VF 56 hyperplastic polyps 56 ischemic 56 urolithiasis 56 catheter angiography 56 obstructive coronary artery 56 proton MR spectroscopy 56 cingulate cortex 56 prehypertensive 56 hsCRP levels 56 atherothrombosis 56 Neurofibromatosis type 56 hypermethylated 56 chromosome #p#.# 56 ADAS Cog 56 LRRK2 mutation 56 symptomatic aortic stenosis 56 serum calcium levels 56 repolarization 56 chromosomal deletions 56 cardiac abnormalities 56 infantile hemangiomas 56 BRCA mutations 56 Observational studies 56 pituitary adenomas 56 loop diuretics 56 TCF#L# gene 56 demyelinating 56 anterior cingulate gyrus 56 ApoE4 gene 56 CK MB 56 binocular rivalry 56 normotensive 56 dietary folate intake 56 #F FDG PET 56 viable myocardium 56 metachronous 56 arterial stiffness 56 cirrhotic 56 epilepsies 56 hemoglobin A1c levels 56 frontal lobe dysfunction 56 dopamine receptor gene 56 dorsolateral prefrontal cortex 56 neurofibromatosis type 56 denervation 56 acute aortic dissection 56 colorectal tumors 56 cerebrovascular accident 56 lobular carcinoma 56 parasympathetic tone 56 multi infarct dementia 56 vermis 56 narrowed carotid arteries 56 K ras mutations 56 T2D 56 serum IGF 56 hypoglycemic episodes 56 blood oxygenation 56 MADRS score 56 pancreatic adenocarcinoma 56 ejection fraction 56 quantitative EEG 56 pilocytic astrocytomas 56 adenotonsillectomy 56 myocardial viability 56 pain syndromes 56 lung edema 56 Alzheimer disease pathology 56 Myocardial infarction 56 histologic subtypes 56 familial hypercholesterolemia 56 Papillary 56 hyperhomocysteinemia 56 Visual acuity 56 ANCA associated 56 osteochondromas 56 ccRCC 56 CT angiograms 56 akinetic mutism 56 primary visual cortex 56 prognostic significance 56 radiographic findings 56 premotor 56 intractable epilepsy 56 Hemorrhagic strokes 56 cervical lymph nodes 56 ipsilateral 56 revascularization procedure 56 cTnT levels 56 BRCA1 mutation carriers 56 diastolic blood pressures 56 preterm deliveries 56 knee osteoarthritis OA 56 myocardial infarction 56 postoperative pulmonary 56 contralateral breast cancer 56 transaminase elevations 55 rs# [003] 55 LDL particle 55 hamartoma 55 lobular cancer 55 Preoperatively 55 karyotype 55 cerebrovascular disease 55 dissociative symptoms 55 nodal metastasis 55 cerebral perfusion 55 SORL1 55 paricalcitol 55 nonvertebral fractures 55 metaplasia 55 microdeletions 55 unmeasured factors 55 basilar 55 brain scans 55 #q#.# [001] 55 HbA1C levels 55 arteriolar 55 tryptophan depletion 55 endometrial thickness 55 BMI z 55 glial tumors 55 ApoE4 carriers 55 lipid lowering therapy 55 cilostazol 55 hyperinsulinemia 55 adenocarcinomas 55 histologic subtype 55 TNF blocker therapy 55 cerebrovascular diseases 55 myoclonus 55 motor neuron degeneration 55 globus pallidus